Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01490216 · ClinicalTrials.gov registry record · Phase 1
Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
A Phase 1 study, sponsored by University of Minnesota.
- Terminated
- Registry status
- Phase 1
- Development phase
- 43
- Enrollment target
NCT01490216 is a Phase 1 study that was terminated before completion, run by University of Minnesota. The registered enrollment target is 43 participants.
The verdict
NCT01490216, a Phase 1 study, was terminated before completion, sponsored by University of Minnesota.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate ideal dose or lisdexamfetamine and tolerability, plus reduction in cocaine use and craving.
Interventions
- DRUG lisdexamfetamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2011-07 |
| Est. Completion | 2013-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01490216
The ClinicalTrials.gov registry entry for NCT01490216 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which lisdexamfetamine is the first listed.
NCT01490216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01490216 about?
NCT01490216 is a clinical study titled "Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence". The purpose of this study is to evaluate ideal dose or lisdexamfetamine and tolerability, plus reduction in cocaine use and craving.
What is the current status of trial NCT01490216?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 43 participants. The study started on 2011-07. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01490216?
The interventions under investigation include: lisdexamfetamine (DRUG).
Who is sponsoring clinical trial NCT01490216?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.